BAL PHARMA - 3 YEARS OF SUPPLY ZONE BREAKOUT3 YEARS OF SUPPLY ZONE BREAKOUT STOCK FOR SWING TRADING
BUY PRICE : 140
SL : 107 (only for swing traders)
TARGET : 215 (52%)
Disclaimer - All information on this page is for educational purposes only, we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financia
4.58 INR
73.92 M INR
3.39 B INR
About BAL PHARMA LTD.
Sector
Industry
CEO
Shailesh Dheerajmal Siroya
Website
Headquarters
Bangalore
Founded
1987
ISIN
INE083D01012
FIGI
BBG000BZBRG0
Bal Pharma Ltd. is a holding company, which engages in the research, development, and commercialization of pharmaceutical products. It offers prescription drugs, generic medicines, and over-the-counter products. The company was founded on May 19, 1987 and is headquartered in Bangalore, India.
Darvas Box Strategy - Breakout StockDisclaimer: I am Not SEBI Registered adviser, please take advise from your financial adviser before investing in any stocks. Idea here shared is for education purpose only.
Stock has given break out. Buy above the High and do not forget to keep stop loss best suitable for swing trading. Keep this s
Bal Pharma LtdBal Pharma Ltd, BALPL is a fully integrated pharmaceuticals company specialising in Bulk Drugs, Prescription Drugs, Generics, Pharma intermediates, and Ayurvedic products. Company focuses on therapeutic areas viz. Anti-diabetes, Anti-histamine, Anti-inflammatory, Acne Treatment, Gastroenterology, Ca
Bal Pharma India Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutua
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of BALPHARMA is 107.51 INR — it has decreased by −2.81% in the past 24 hours. Watch BAL PHARMA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange BAL PHARMA LTD. stocks are traded under the ticker BALPHARMA.
BALPHARMA stock has risen by 2.46% compared to the previous week, the month change is a 16.80% rise, over the last year BAL PHARMA LTD. has showed a 6.55% increase.
BALPHARMA reached its all-time high on Jan 13, 2016 with the price of 167.90 INR, and its all-time low was 13.15 INR and was reached on Mar 5, 2009. View more price dynamics on BALPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BALPHARMA stock is 4.09% volatile and has beta coefficient of 0.40. Track BAL PHARMA LTD. stock price on the chart and check out the list of the most volatile stocks — is BAL PHARMA LTD. there?
Today BAL PHARMA LTD. has the market capitalization of 1.73 B, it has decreased by −1.42% over the last week.
Yes, you can track BAL PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
BALPHARMA net income for the last quarter is 4.81 M INR, while the quarter before that showed 10.42 M INR of net income which accounts for −53.82% change. Track more BAL PHARMA LTD. financial stats to get the full picture.
Yes, BALPHARMA dividends are paid annually. The last dividend per share was 1.20 INR. As of today, Dividend Yield (TTM)% is 1.10%. Tracking BAL PHARMA LTD. dividends might help you take more informed decisions.
BAL PHARMA LTD. dividend yield was 1.32% in 2023, and payout ratio reached 25.66%. The year before the numbers were 1.49% and 61.01% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 25, 2025, the company has 868 employees. See our rating of the largest employees — is BAL PHARMA LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAL PHARMA LTD. EBITDA is 315.11 M INR, and current EBITDA margin is 9.86%. See more stats in BAL PHARMA LTD. financial statements.
Like other stocks, BALPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAL PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAL PHARMA LTD. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAL PHARMA LTD. stock shows the buy signal. See more of BAL PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.